This announcement is a separate document:
Nektar Therapeutics | 8-K: Current report
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
11:00
In South Korea, the year-on-year L MMF supply for October is 6.1%, with the previous value revised from 5.6% to 5.6%.
10:54
According to Fu Linghui, spokesperson for the National Bureau of Statistics, based on the annual situation, the economic and social development goals for this year are likely to be successfully achieved. (Xinhua Finance)
10:54
The Shanghai Stock Exchange requires brokerage firms to conduct self-checks on financial, customer transactions, and investment banking businesses